Notwithstanding the Bill’s objectives, which I can see are admirable, does the Secretary of State accept that hundreds of millions of pounds could be saved in the drugs budget if there was better analysis of NHS prescription patterns? I have called before for the appointment of analytical pharmacists to look at the balance between prescription efficacy and cost and at trying to increase the use of biosimilars. Some of that £1.24 billion could be invested in that greater analysis.
Health Service Medical Supplies (Costs) Bill
Proceeding contribution from
Kit Malthouse
(Conservative)
in the House of Commons on Monday, 24 October 2016.
It occurred during Debate on bills on Health Service Medical Supplies (Costs) Bill.
About this proceeding contribution
Reference
616 c75Session
2016-17Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2020-04-14 16:59:29 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2016-10-24/16102429000024
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2016-10-24/16102429000024
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2016-10-24/16102429000024